Viemed shareholders approve 2M-share 2024 LTIP; directors elected with notable withhold votes

VIEMED HEALTHCARE, INC.

Shareholders approved 2024 Long Term Incentive Plan authorizing up to 2,000,000 common shares for equity awards.
Plan passed with 69.21% for, 30.79% against (excluding 4,302,487 broker non-votes).
Eight directors elected; Bruce Greenstein had highest withhold at 18.61%, followed by Nitin Kaushal (15.58%) and Timothy Smokoff (13.74%).
Appointment of Ernst & Young as auditors ratified with 99.67% for.
Broker non-votes of 4,302,487 on director elections and plan vote.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.